Leukemia

SJR Rank #506H-index: 235SJR: 3.675Best quartile: Q1APC: US$5,190
Journal website: aims, scope and author guidelines
Publisher

Springer Nature

Country

United Kingdom

Type

journal

SJR by Edition

2022202500.951.92.853.8

Subject Categories

  • Anesthesiology and Pain MedicineQ1
  • Cancer ResearchQ1
  • HematologyQ1
  • OncologyQ1

Areas: Biochemistry, Genetics and Molecular Biology · Medicine

Most published research topics

Acute Myeloid Leukemia ResearchChronic Lymphocytic Leukemia ResearchChronic Myeloid Leukemia TreatmentsAcute Lymphoblastic Leukemia researchLymphoma Diagnosis and TreatmentMyeloproliferative Neoplasms: Diagnosis and TreatmentMultiple Myeloma Research and TreatmentsHematopoietic Stem Cell TransplantationImmune Cell Function and InteractionProtein Degradation and Inhibitors

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs02505007501000

Documents per Year

20222025090180270360

Detailed Information

ISSN

0887-6924, 1476-5551

SJR Best Quartile

Q1

Region

Western Europe

Citations per Document (2 years)

6.24

References per Document

42.52

Coverage

1987-2026

Scope

Leukemia publishes high quality, peer reviewed research that covers all aspects of the research and treatment of leukemia and allied diseases. Studies of normal hemopoiesis are covered because of their comparative relevance. Topics of interest include oncogenes, growth factors, stem cells, leukemia genomics, cell cycle, signal transduction, molecular targets for therapy and more. We publish a range of content types including original research articles, reviews, letters, correspondence and comments that elaborate on significant advances in the field and cover topical issues.

Metrics from SCImago Journal Rank 2025. View on SCImago